NXL Nexalin Technology Inc.

Nexalin Technology Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Sr. VP - Quality, Regulatory Shelton Carolyn Hamby bought $13,200 worth of shares (6,000 units at $2.20) (SEC Form 4)
4 - Nexalin Technology, Inc. (0001527352) (Issuer)
3/13/25 4:52:26 PM ET
$NXL
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
SEC Form 4 filed by President and CEO White Mark
4 - Nexalin Technology, Inc. (0001527352) (Issuer)
2/27/25 4:34:13 PM ET
$NXL
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
SEC Form 4 filed by Chief Medical Officer Owens David
4 - Nexalin Technology, Inc. (0001527352) (Issuer)
2/27/25 4:33:38 PM ET
$NXL
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Shelton Carolyn Hamby bought $20,400 worth of shares (24,000 units at $0.85) (SEC Form 5)
5 - Nexalin Technology, Inc. (0001527352) (Issuer)
2/10/25 6:21:16 PM ET
$NXL
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Chief Medical Officer Owens David bought $3,100 worth of shares (1,000 units at $3.10), increasing direct ownership by 0.65% to 155,793 units (SEC Form 4)
4 - Nexalin Technology, Inc. (0001527352) (Issuer)
2/5/25 3:17:26 PM ET
$NXL
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Chief Medical Officer Owens David bought $2,980 worth of shares (1,000 units at $2.98), increasing direct ownership by 0.65% to 154,793 units (SEC Form 4)
4 - Nexalin Technology, Inc. (0001527352) (Issuer)
2/4/25 5:05:25 PM ET
$NXL
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Owens David bought $2,750 worth of shares (1,000 units at $2.75), increasing direct ownership by 0.67% to 149,293 units (SEC Form 5)
5 - Nexalin Technology, Inc. (0001527352) (Issuer)
1/29/25 5:26:11 PM ET
$NXL
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
SEC Form 5 filed by Kazden Alan
5 - Nexalin Technology, Inc. (0001527352) (Issuer)
1/29/25 5:25:16 PM ET
$NXL
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Chief Medical Officer Owens David bought $4,050 worth of shares (1,500 units at $2.70), increasing direct ownership by 0.98% to 153,793 units (SEC Form 4)
4 - Nexalin Technology, Inc. (0001527352) (Issuer)
1/29/25 5:22:23 PM ET
$NXL
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Chief Medical Officer Owens David bought $7,700 worth of shares (3,000 units at $2.57), increasing direct ownership by 2% to 152,293 units (SEC Form 4)
4 - Nexalin Technology, Inc. (0001527352) (Issuer)
1/24/25 4:55:25 PM ET
$NXL
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care

Nexalin Technology Inc.

Recent Analyst Ratings for Nexalin Technology Inc.

Nexalin Technology Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Sr. VP - Quality, Regulatory Shelton Carolyn Hamby bought $13,200 worth of shares (6,000 units at $2.20) (SEC Form 4)

SEC Form 4 filed by President and CEO White Mark

SEC Form 4 filed by Chief Medical Officer Owens David

Shelton Carolyn Hamby bought $20,400 worth of shares (24,000 units at $0.85) (SEC Form 5)

Chief Medical Officer Owens David bought $3,100 worth of shares (1,000 units at $3.10), increasing direct ownership by 0.65% to 155,793 units (SEC Form 4)

Chief Medical Officer Owens David bought $2,980 worth of shares (1,000 units at $2.98), increasing direct ownership by 0.65% to 154,793 units (SEC Form 4)

Owens David bought $2,750 worth of shares (1,000 units at $2.75), increasing direct ownership by 0.67% to 149,293 units (SEC Form 5)

SEC Form 5 filed by Kazden Alan

Chief Medical Officer Owens David bought $4,050 worth of shares (1,500 units at $2.70), increasing direct ownership by 0.98% to 153,793 units (SEC Form 4)

Chief Medical Officer Owens David bought $7,700 worth of shares (3,000 units at $2.57), increasing direct ownership by 2% to 152,293 units (SEC Form 4)